Skip to main content
ArticleOPEN ACCESS

Only connect: The merger of BMC Pharmacology and BMC Clinical Pharmacology

BMC Pharmacology and Toxicology
DOI: 10.1186/2050-6511-13-1
1Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This editorial celebrates the launch of BMC Pharmacology and Toxicology within the BMC series of journals published by BioMed Central. The scope of the journal is interdisciplinary encompassing toxicology, experimental and clinical pharmacology including clinical trials. In this editorial we discuss the origins of this new journal and the ethos and policies under which it will operate. © 2012 Moylan et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Moylan, E. C., Morrey, C., & Appleford-Cook, J. M. (2012, August 13). Only connect: The merger of BMC Pharmacology and BMC Clinical Pharmacology. BMC Pharmacology and Toxicology. https://doi.org/10.1186/2050-6511-13-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free